Bnp Paribas Asset Management Holding S.A. Tarsus Pharmaceuticals, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 314 shares of TARS stock, worth $22,337. This represents 0.0% of its overall portfolio holdings.
Number of Shares
314Holding current value
$22,337% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
215Shares Held
46.9MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$232 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$221 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$212 Million5.63% of portfolio
-
Jennison Associates LLC2.6MShares$185 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$175 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.9B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...